Physician
Fort Washington Park Pediatrics P.C.
Fort Washington Park Pediatrics P.C. was paid $1.84M by Medicaid between Sep 2018 and Dec 2024, across 51 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoFORT WASHINGTON PARK PEDIATRICS P.C.
ROSEDALE, MD 21237
ROSEDALE, MD 21237
33aNPI1023558384assigned 03/06/2017
33bProvider typePediatrics Physician
28Total paid$1.84M
24GClaims41,607
24DCodes billed51
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#65 of 306
Median peer was paid$206K
This provider vs. median8.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18 | $448.56 | |
| 2019 | 138 | $3K | |
| 2020 | 8,394 | $301K | |
| 2021 | 7,732 | $309K | |
| 2022 | 9,030 | $412K | |
| 2023 | 8,211 | $408K | |
| 2024incomplete | 8,084 | $405K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 8,088 | 6,924 | $714K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 2,697 | 2,348 | $306K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10% | 1,861 | 1,700 | $184K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.0% | 1,570 | 1,513 | $166K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.0% | 891 | 849 | $92K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 380 | 355 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 3,256 | 2,980 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 2,158 | 1,352 | $34K |
| 92552 | 1.6% | 1,257 | 1,188 | $30K | |
| 90677 | 1.5% | 324 | 317 | $28K | |
| D1206 | Topical application of fluoride varnish | 1.2% | 846 | 840 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 423 | 404 | $20K |
39 more codes
| 90670 | 1.0% | 805 | $19K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,591 | $18K |
| 90686 | <1% | 742 | $16K | |
| 90697 | <1% | 343 | $15K | |
| 90698 | <1% | 588 | $14K | |
| 92551 | <1% | 1,189 | $11K | |
| 90680 | <1% | 344 | $8K | |
| 94760 | <1% | 5,225 | $8K | |
| 96127 | <1% | 834 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 264 | $5K |
| 87807 | <1% | 433 | $5K | |
| 99173 | <1% | 1,609 | $4K | |
| 99177 | <1% | 831 | $4K | |
| 90633 | <1% | 157 | $3K | |
| 90744 | <1% | 144 | $3K | |
| 90710 | <1% | 90 | $3K | |
| 81002 | <1% | 1,158 | $2K | |
| 90619 | <1% | 30 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 14 | $2K |
| 99381 | <1% | 14 | $2K | |
| 90651 | <1% | 68 | $2K | |
| 99383 | <1% | 15 | $1K | |
| 90734 | <1% | 54 | $1K | |
| 90656 | <1% | 57 | $1K | |
| 96161 | <1% | 422 | $1K | |
| 90696 | <1% | 47 | $1K | |
| 90715 | <1% | 31 | $721.68 | |
| 96160 | <1% | 136 | $371.46 | |
| 99050 | <1% | 67 | $331.05 | |
| 90707 | <1% | 14 | $325.92 | |
| 90716 | <1% | 13 | $302.64 | |
| 90687 | <1% | 12 | $259.68 | |
| 99051 | <1% | 87 | $176.30 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 13 | $120.00 |
| 3008F | <1% | 82 | $51.00 | |
| 36416 | <1% | 201 | $21.50 | |
| 99000 | <1% | 85 | $12.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 16 | $3.82 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGUILAR, EDWIN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Riverdale Park Pediatrics PC | Riverdale, MD | $9.90M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.